Back to Search
ANDREW MILLER, MD
MD
General Practice Physician
NPI: 1861421117IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
MD26750(OR)
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
MD26750(OR)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OTHER
Class of 2003
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
Residential mobility during pregnancy: patterns and correlates.
PMID 19568920·Matern Child Health J·2010
8-other
Freeways in the plant: transporters for N, P and S and their regulation.
PMID 19481499·Curr Opin Plant Biol·2009
6-review
Lip reconstruction with combined cutaneous and mucosal pedicle flaps.
PMID 19438674·Dermatol Surg·2009
5-case
Identification of protein cofactors necessary for sequence-specific plasmid DNA nuclear import.
PMID 19532138·Mol Ther·2009
8-other
Spatial scale and opportunities for choice influence browsing and associational refuges of focal plants.
PMID 19594661·J Anim Ecol·2009
7-preclinical
Fluorescence cross-correlation spectroscopy as a universal method for protein detection with low false positives.
PMID 19522509·Anal Chem·2009
8-other
Pediatric cardiopulmonary bypass circuits: a review of studies conducted at the Penn State Pediatric Cardiac Research Laboratories.
PMID 19361042·J Extra Corpor Technol·2009
6-review
Tissue-specific and transcription factor-mediated nuclear entry of DNA.
PMID 19393704·Adv Drug Deliv Rev·2009
6-review
Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus).
PMID 19605896·Vet Pathol·2009
7-preclinical
Dual-energy X-ray absorptiometry is the method of choice to assess body composition in COPD.
PMID 19353776·Respirology·2009
4-observational
cis-Inhibition of Notch by endogenous Delta biases the outcome of lateral inhibition.
PMID 19631544·Curr Biol·2009
7-preclinical
Zirconocene-mediated macrocyclizations of diynes containing di-o-methylphenylene spacers.
PMID 19323577·J Org Chem·2009
8-other
Direct visualization for syndesmotic stabilization of ankle fractures.
PMID 19439142·Foot Ankle Int·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 335 SE 8TH AVE
HILLSBORO, OR 97123 - Phone
- (503) 681-1111
Quick Facts
- NPI
- 1861421117
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 23
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile